Tasquinimod for the Treatment of Relapsed or Refractory Myeloma
NCT04405167
Age 18 +
Sex Both
Phase Phase 1
Third Opinion Trial Synopsis
Doctors are studying a new medicine called tasquinimod to see if it can help people with a type of cancer called multiple myeloma. This is the first study of this medicine for this type of cancer.
Doctors are studying a new medicine called tasquinimod to see if it can help people with a type of cancer called multiple myeloma. This is the first study of this medicine for this type of cancer.
Third Opinion AI Generated Synopsis
Trial Summary
This study is the first study of tasquinimod, an inhibitor of S100A9, in patients with multiple myeloma.
This study is the first study of tasquinimod, an inhibitor of S100A9, in patients with multiple myeloma.
from ClinicalTrials.gov
Locations & Contact
Fill out the form and to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts:
